Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	77.39	170.2	62.53	50.19	12.88
Short-Term Investments	99.11	201.16	284.42	45.93	-
Cash & Short-Term Investments	176.5	371.36	346.95	96.12	12.88
Cash Growth	-52.47%	7.04%	260.96%	646.43%	320.13%
Accounts Receivable	0.45	40.05	15.31	-	-
Other Receivables	0.1	0.5	0.5	-	-
Receivables	0.55	40.55	15.81	-	-
Inventory	-	38.32	9.77	-	-
Prepaid Expenses	12.38	14.43	9.61	5.39	0.76
Other Current Assets	-	-	-	3.44	-
Total Current Assets	189.43	464.67	382.13	104.95	13.64
Property, Plant & Equipment	2.73	6.41	8.14	0.47	0.15
Other Long-Term Assets	1.47	46.38	1.19	0.19	0.31
Total Assets	193.63	517.45	391.45	105.61	14.1
Accounts Payable	2.94	22.06	6.26	4.37	3.61
Accrued Expenses	23.95	57.72	38.31	13.02	3.71
Current Portion of Leases	1.52	2.26	2.04	-	-
Total Current Liabilities	28.41	82.04	46.61	17.4	7.33
Long-Term Debt	-	-	-	-	1.43
Long-Term Leases	0.46	1.98	4.24	-	-
Other Long-Term Liabilities	-	-	-	0.04	0.02
Total Liabilities	28.87	84.02	50.85	17.43	8.77
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-In Capital	771.54	738.18	694.91	4.67	1.19
Retained Earnings	-606.69	-304.95	-354.22	-155.85	-67.91
Comprehensive Income & Other	-0.09	0.2	-0.09	0.01	-
Total Common Equity	164.77	433.43	340.61	-151.17	-66.73
Shareholders' Equity	164.77	433.43	340.61	88.18	5.34
Total Liabilities & Equity	193.63	517.45	391.45	105.61	14.1
Total Debt	1.98	4.24	6.28	-	1.43
Net Cash (Debt)	174.52	367.13	340.67	96.12	11.45
Net Cash Growth	-52.46%	7.77%	254.43%	739.31%	-
Net Cash Per Share	2.56	5.25	5.82	14.59	1.88
Filing Date Shares Outstanding	88.6	67.78	66.72	57.86	6.43
Total Common Shares Outstanding	68.63	66.51	66.51	7.02	5.99
Working Capital	161.03	382.62	335.52	87.56	6.31
Book Value Per Share	2.40	6.52	5.12	-21.53	-11.13
Tangible Book Value	164.77	433.43	340.61	-151.17	-66.73
Tangible Book Value Per Share	2.40	6.52	5.12	-21.53	-11.13
Machinery	1.92	3.55	2.17	0.34	0.05
Construction In Progress	0.22	0.59	0.8	0.14	0.06
Leasehold Improvements	0.18	0.18	0.18	0.05	0.04

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q